These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 28764970
1. Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity. Wani S, Kaul D, Mavuduru RS, Kakkar N, Bhatia A. J Biotechnol; 2017 Oct 10; 259():135-139. PubMed ID: 28764970 [Abstract] [Full Text] [Related]
2. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis. Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X. Prostate; 2017 May 10; 77(6):573-583. PubMed ID: 27990656 [Abstract] [Full Text] [Related]
3. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic. Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A. Prostate; 2016 Jan 10; 76(1):68-79. PubMed ID: 26417675 [Abstract] [Full Text] [Related]
4. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer. Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ. Prostate; 2019 Jan 10; 79(1):88-95. PubMed ID: 30194772 [Abstract] [Full Text] [Related]
5. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis. Barceló M, Castells M, Bassas L, Vigués F, Larriba S. Sci Rep; 2019 Sep 24; 9(1):13772. PubMed ID: 31551516 [Abstract] [Full Text] [Related]
6. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer. Wang YH, Ji J, Wang BC, Chen H, Yang ZH, Wang K, Luo CL, Zhang WW, Wang FB, Zhang XL. Cell Physiol Biochem; 2018 Sep 24; 46(2):532-545. PubMed ID: 29614511 [Abstract] [Full Text] [Related]
7. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A. Mol Cancer; 2017 Oct 05; 16(1):156. PubMed ID: 28982366 [Abstract] [Full Text] [Related]
8. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls. Güllü Amuran G, Tinay I, Filinte D, Ilgin C, Peker Eyüboğlu I, Akkiprik M. Int Urol Nephrol; 2020 Mar 05; 52(3):461-468. PubMed ID: 31679136 [Abstract] [Full Text] [Related]
9. Urinary exosomal microRNA profiling in intermediate-risk prostate cancer. Kim MY, Shin H, Moon HW, Park YH, Park J, Lee JY. Sci Rep; 2021 Apr 01; 11(1):7355. PubMed ID: 33795765 [Abstract] [Full Text] [Related]
10. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Corcoran C, Rani S, O'Driscoll L. Prostate; 2014 Sep 01; 74(13):1320-34. PubMed ID: 25053345 [Abstract] [Full Text] [Related]
11. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome. Chen T, Wang C, Yu H, Ding M, Zhang C, Lu X, Zhang CY, Zhang C. EBioMedicine; 2019 Jan 01; 39():552-561. PubMed ID: 30467011 [Abstract] [Full Text] [Related]
12. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children. Huang Z, Zhang Y, Zhou J, Zhang Y. Biomed Res Int; 2017 Jan 01; 2017():7298160. PubMed ID: 28246603 [Abstract] [Full Text] [Related]
13. Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer. Hosseini M, Khatamianfar S, Hassanian SM, Nedaeinia R, Shafiee M, Maftouh M, Ghayour-Mobarhan M, ShahidSales S, Avan A. Curr Pharm Des; 2017 Jan 01; 23(11):1705-1709. PubMed ID: 27908272 [Abstract] [Full Text] [Related]
14. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L. Prostate; 2017 Jul 01; 77(10):1167-1175. PubMed ID: 28617988 [Abstract] [Full Text] [Related]
15. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes. Joković SM, Dobrijević Z, Kotarac N, Filipović L, Popović M, Korać A, Vuković I, Savić-Pavićević D, Brajušković G. Genes (Basel); 2022 Dec 09; 13(12):. PubMed ID: 36553586 [Abstract] [Full Text] [Related]
16. Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory-Based Techniques: Protocol for a Case-Control Study. Li G, Tholance Y, Mallouk N, Waeckel L, Flandrin P, Bali B, Badet L, Cornillon P. JMIR Res Protoc; 2024 Sep 11; 13():e63551. PubMed ID: 39024018 [Abstract] [Full Text] [Related]
17. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer. Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C. Clin Transl Oncol; 2017 Jun 11; 19(6):651-657. PubMed ID: 28054319 [Abstract] [Full Text] [Related]
18. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E. Tumour Biol; 2015 Jun 11; 36(6):4643-53. PubMed ID: 25631748 [Abstract] [Full Text] [Related]
19. Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer. Li W, Dong Y, Wang KJ, Deng Z, Zhang W, Shen HF. Neoplasma; 2020 Nov 11; 67(6):1314-1318. PubMed ID: 32614237 [Abstract] [Full Text] [Related]
20. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells. Yin X, Zheng X, Liu M, Wang D, Sun H, Qiu Y, Chen J, Shi B. Cell Biol Int; 2020 Apr 11; 44(4):958-965. PubMed ID: 31872468 [Abstract] [Full Text] [Related] Page: [Next] [New Search]